Updated Jun 25, 2026
Selected portfolio
Experimental
Top 1 · Monthly · Top-Rated
Rank #14
Risk
Experimental
Risk
Experimental
Stocks included
Top 1
Stocks included
Top 1
Rebalance
Monthly
Rebalance
Monthly
Weighting
Equal weight
Weighting
Equal weight
Key metrics
Since Feb 17, 2026
- +38.4%
Total return
- +30.9%
Performance vs S&P 500
- 2.19
Sharpe ratio
- +152.7%
CAGR
- -14.9%
Max drawdown
What you are looking at
Starting capital: $10,000 simulated. Disclaimer
| # | Stock | Allocation | Return |
|---|---|---|---|
Returns
Risk
Consistency
Want the methodology notes?
See the full methodology, portfolio-ranking rules, and scientific grounding.
Not investment advice. Past performance does not guarantee future results. Full disclaimer